Thanks to a new technology, the diagnosis of brain cancer undergoes a breakthrough. The credit goes to cancer diagnostics company and University of Strathclyde Dxcover spin-out company. The company has indeed launched the liquid biopsy Dxcover, which was also effective in the early days of cancer growth, at a smaller volume and earlier stage.
q
There Research was published in the scientific journal Cancers.
Brain cancer: here are the advantages of the Dxcover liquid biopsy
According to Cancer Research UK, a 12,000 people in Britain are diagnosed with brain cancer each year and survival rates are 12% five years after diagnosis.
Read Also
- Guadeloupe: The region files a complaint for a “large-scale cyberattack” Nov 22, 2022
- Energy: As winter approaches, how EDF manages unpaid bill files Nov 16, 2022
- CyberDog from Xiaomi: the $ 1500 robot of the company Aug 12, 2021
- Alonso wrapped in the ‘orange fog’ | FormulaPassion.it Sep 7, 2021
- F1, the 2022 calendar is outlined: the Jeddah and Miami GPs in March and early May Aug 12, 2021
- Sergio George defends Yahaira Plasencia’s playback: “What if he released 50 roosters? Jul 16, 2021
- Indonesia: 6-year-old boy rescued from rubble two days after quake Nov 25, 2022